Literature DB >> 913926

Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.

G M Shenfield, A Logan, D Shirling, J Baird.   

Abstract

19 diabetic patients taking various doses of chlorpropamide were studied throughout a normal day. Plasma chlorpropamide levels were related to the daily dose of the drug and were relatively constant throughout the day. Blood glucose concentration was highest and the plasma insulin concentration lowest in patients taking the largest dose of chlorpropamide. Patients on a small daily dose of chlorpropamide were well controlled and had higher than normal insulin levels. --12 patients were restudied 10 days after stopping chlorpropamide. Although diabetic control deteriorated in all patients, plasma insulin concentration did not change significantly. This suggests that the long-term hypoglycaemic action of chlorpropamide is not dependent on an effect on the concentration of insulin in peripheral venous blood.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 913926     DOI: 10.1007/bf01223280

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

1.  POTENTIATION OF INSULIN ACTION ON THE LIVER BY TOLBUTAMIDE.

Authors:  A R COLWELL
Journal:  Metabolism       Date:  1964-11       Impact factor: 8.694

2.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

3.  An automated determination of glucose utilizing a glucose oxidase-peroxidase system.

Authors:  J B HILL; G KESSLER
Journal:  J Lab Clin Med       Date:  1961-06

4.  A laboratory and clinical study of chlorpropamide in ambulatory diabetics.

Authors:  M B HANDELSMAN; L LEVITT; M F CALABRETTA
Journal:  Ann N Y Acad Sci       Date:  1959-03-30       Impact factor: 5.691

5.  Chlorpropamide and diabetes mellitus: summary of the monograph.

Authors:  C H BEST
Journal:  Ann N Y Acad Sci       Date:  1959-03-30       Impact factor: 5.691

6.  Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.

Authors:  A J Barnes; K J Garbien; M F Crowley; A Bloom
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

Review 7.  Appraisal of the extrapancreatic actions of sulfonylureas.

Authors:  J M Feldman; H E Lebovitz
Journal:  Arch Intern Med       Date:  1969-03

8.  The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.

Authors:  P C Chu; M J Conway; H A Krouse; C J Goodner
Journal:  Ann Intern Med       Date:  1968-04       Impact factor: 25.391

9.  Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes mellitus.

Authors:  G Reaven; J Dray
Journal:  Diabetes       Date:  1967-07       Impact factor: 9.461

10.  An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals.

Authors:  J C Dunbar; P P Foà
Journal:  Diabetologia       Date:  1974-02       Impact factor: 10.122

View more
  10 in total

Review 1.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

2.  Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone.

Authors:  P H Sönksen; C Lowy; J R Perkins; T E West
Journal:  Diabetologia       Date:  1981       Impact factor: 10.122

3.  Disposition and hypoglycaemic action of glipizide in diabetic patients given a single dose of nifedipine.

Authors:  A A Connacher; A H el Debani; T E Isles; I H Stevenson
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment.

Authors:  K Kosaka; T Kuzuya; Y Akanuma; R Hagura
Journal:  Diabetologia       Date:  1980-01       Impact factor: 10.122

Review 5.  Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.

Authors:  R Huupponen
Journal:  Med Toxicol       Date:  1987 May-Jun

6.  The effect of acebutolol and propranolol on the hypoglycaemic action of glibenclamide.

Authors:  R Zaman; M J Kendall; P I Biggs
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

7.  The regulation of glucose-induced insulin secretion by pre-stimulus glucose level and tolbutamide in normal man.

Authors:  M A Pfeifer; R J Graf; J B Halter; D Porte
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

8.  Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.

Authors:  J P Hosker; M A Burnett; E G Davies; E A Harris; R C Turner
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122

9.  Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.

Authors:  L Groop; E Wåhlin-Boll; P H Groop; K J Tötterman; A Melander; E M Tolppanen; F Fyhrqvist
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

10.  Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus.

Authors:  M E Britton; A E Denver; V Mohamed-Ali; J S Yudkin
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 3.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.